Neurodegeneratieve ziektes
15 important questions on Neurodegeneratieve ziektes
Parkinsons disease symptoms
–Tremor (4-7 Hz) of the limbs
–Increased muscle tone
–Muscle rigidity
–Difficulty in initiating movements (akinesia)
–Slow movements (bradykinesia)
–Mask-like facial expression
–Low eye blink rate
–Bend back during walking
–Shuffling gait
Parkinsons disease etiology (two variants)
–Mutations in the gene encoding a synuclein
–Presence of Lewy bodies
•Sporadic PD
–Head trauma
–Brain tumors
–Environmental toxins, -MPTP (MPTP is een organische verbinding die toxische effecten heeft op de substantia nigra, een gebied in de hersenen dat onder andere de motoriek regelt. MPTP zorgt ervoor dat cellen afsterven, waardoor het gebied zijn functie niet meer kan uitoefenen)
Parkinsons disease: neuropathology
•A 50% loss of SNpc neurons is necessary for onset of symptoms, SNpc neurons die from oxidative stress
–Other dopamine neurons, noradrenergic neurons and cholinergic neurons also die, but to a lesser extent
So: Normally, misfolded proteins are degraded, in PD, mutated synuclien accumulates in Lewy bodies, this causes oxidative stress and neurodegeneration
- Higher grades + faster learning
- Never study anything twice
- 100% sure, 100% understanding
How do SNpc neurons die from oxidative stress in Parkinsons disease?
oxidative stress plays a central role in the degeneration and death of SNpc neurons in Parkinson's disease by causing mitochondrial dysfunction, oxidative damage, protein aggregation, and activation of cell death pathways.
–DA metabolism enhances oxygen radical formation
–Neuromelanin binds Fe++ and promotes hydroxyl radical formation
Lewy bodies in Parkinsons Disease
The histological hallmark of Parkinson's disease (PD) is the presence of fibrillar aggregates called Lewy bodies (LBs). LB formation has been considered to be a marker for neuronal degeneration, because neuronal loss is found in the predilection sites for LBs.
Composition:
Cytoplasmic inclusions with a core of a-synuclein (protein that is mutated in PD) and a halo of ubiquitin (small protein that is coupled to other proteins and marks these proteins for degradation )
Braak stages of Parkinson disease
2. Laesies medulla oblongata
3. Substantia nigra (more and more accumulating lewy bodies)
4. Ernstige beschadiging doparmergic neurons
5. Neocortex and lobes
6. Whole neocortex, bad movement and perception
Earliest affected brain areas in PD?
–The earliest affected brain structures in PD are the dorsal nuclei in the brain stem and the olfactory bulb
Pharmacological treatment PD (4)
•L-DOPA (+ DOPA decarboxylase inhibitor)
–Increases dopamine synthesis
•MAO inhibitors
–Prevents breakdown of dopamine
•Antioxidants (vitamin E)
–Bind free oxygen radical
•Dopamine receptor agonists
–Stimulate dopamine receptors on striatal neurons
Surgical treatment PD (3)
-Lesioning specific output regions of the striatum reduce PD symptoms in animals and humans
•Cell or tissue transplantation
-Transplantation of fetal SNpc tissue or neurons results in partial improvement (Ethical concerns, alternative sources for dopamine neurons (stem cells))
•Deep Brain Stimulation
-involves implanting electrodes into specific areas of the brain and delivering electrical impulses to modulate abnormal neuronal activity.
Deep Brain Stimulation Parkinsons Disease
Alzheimers Disease: prevalence & symptoms
–Commonest cause of dementia in the elderly (Affects 5% of people over 70 and 20% of people over 80)
–Causes serious cognitive impairment
•Loss of memory
•Decreased attention and motivation
–Progression is uneven in different individuals (Stress can accelerate progression)
–Most AD patients also have PD and suffer from depression
–Life expectancy after diagnosis is ~5 years
Neuritic plaques and neurofibrillary tangles in AD
•Neuritic plaques
–Extracellular lesions containing an insoluble form of the peptide b-amyloid (Ab)
•Neurofibrillary tangles
–Cytoplasmic bundles of hyper-phosphorylated tau proteins
Alpha beta gamma secretases AD
- Alpha-secretase: Cleaves amyloid precursor protein (APP) within its transmembrane domain, preventing the formation of amyloid-beta (Aβ) peptides.
- Beta-secretase (BACE): Cleaves APP at the N-terminus of the Aβ peptide sequence, leading to the production of Aβ peptides, which aggregate to form amyloid plaques in Alzheimer's disease.
- Gamma-secretase: Cleaves the C99 fragment generated by beta-secretase, releasing the Aβ peptide.
AD: why is beta-amyloid toxic? (3)
Toxic:
–When Ab binds Cu++ it produces H2O2 and causes oxidative stress
–Small Ab aggregates cause damage to axons and synapses
–Ab-derived diffusible ligands (ADDLs) may specifically impair synaptic function (inhibit LTP) and cause neuronal apoptosis
Pharmacological treatment AD (7, not all succesful)
-Anti-inflammatory drugs (indomethacin): Targets inflammatory components of AD.
-Vaccination against Ab: Not successful. Causes brain inflammation.
-Chelating agents (clioquinol): Binds Cu++ and Zn++.
-Antioxidants: Bind free oxygen radicals.
-Neurotrophins: Proteins that promote neuronal survival and growth.
-Inhibitors of b- and g-secretase
The question on the page originate from the summary of the following study material:
- A unique study and practice tool
- Never study anything twice again
- Get the grades you hope for
- 100% sure, 100% understanding